Astragaloside IV attenuates allergic inflammation by regulation Th1/Th2 cytokine and enhancement CD4+CD25+Foxp3 T cells in ovalbumin-induced asthma

Immunobiology

Volumn 219, Issue 7, 2014, Pages 565-571

  Huang, Xianfeng ^a   Tang, Long ^a   Wang, Fan ^a   Song, Guoqiang ^a  

^a CHANGZHOU UNIVERSITY   (China)

Author keywords

Asthma; Astragaloside IV; Th1 Th2; Treg

Indexed keywords

ASTRAGALOSIDE IV; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; OVALBUMIN; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; ASTRAGALOSIDE A; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HERBACEOUS AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; SAPONIN; TRITERPENE;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIASTHMATIC ACTIVITY; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE; TREATMENT DURATION; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BRONCHIAL HYPERREACTIVITY; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DRUGS, CHINESE HERBAL; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; LUNG; MICE, INBRED BALB C; OVALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPONINS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRITERPENES;

EID: 84900397715     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.03.005     Document Type: Article

References (25)

1. Brewer J.M., Conacher M., Hunter C.A., Mohrs M., Brombacher F., Alexander J. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J. Immunol. 1999, 163:6448-6454.
2. Galli S.J., et al. The development of allergic inflammation. Nature 2008, 454:445-454.
3. Huang L.F., Yao Y.M., Dong N., Yu Y., He L.X., Sheng Z.Y. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Crit. Care 2010, 14:R3.
4. Jie Z., et al. The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation. Respir. Physiol. Neurobiol. 2009, 168:289-294.
5. + regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin. Exp. Immunol. 2007, 148:53-63.
6. Lee J.J., McGarry M.P., Farmer S.C., Denzler K.L., Larson K.A., Carrigan P.E., Brenneise I.E., Horton M.A., Haczku A., Gelfand E.W., Leikauf G.D., Lee N.A. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 1997, 185:2143-2156.
7. Lopez A.F. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988, 167:219-224.
8. + T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann. Surg. 2006, 244:514-523.
9. Medoff B.D., et al. T cell trafficking in allergic asthma: the ins and outs. Annu. Rev. Immunol. 2008, 26:205-232.
10. Oh J.W., Seroogy C.M., Meyer E.H., Akbari O., Berry G., Fathman C.G., et al. CD4 Thelper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J. Allergy Clin. Immunol. 2002, 110:460-468.
11. Royer B., Varadaradjalou S., Saas P., Guillosson J., Kantelip J., Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 2001, 31:694-704.
12. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006, 212:8-27.
13. Sanderson C.J. Interleukin-5, eosinophils, and disease. Blood 1992, 79:3101-3109.
14. Simon D., et al. Eosinophils and atopic dermatitis. Allergy 2004, 59:561-570.
15. Takanaski S., Nonaka R., Xing Z., O'Byrne P., Dolovich J., Jordana M. Interleukin-10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 1994, 180:711-715.
16. Tanaka H., Masuda T., Tokuoka S., Komai M., Nagao K., Takahashi Y., Nagai H. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflam. Res. 2001, 50:616-624.
17. Tohda C., Tamura T., Matsuyama S., Komatsu K. Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. Br. J. Pharmacol. 2006, 149:532-541.
18. + cells in human allergic diseases. J. Allergy Clin. Immunol. 1997, 100:1-6.
19. Umetsu D.T., DeKruyff R.H. The regulation of allergy and asthma. Immunol. Rev. 2006, 212:238-255.
20. Venuprasad K., Elly C., Gao M., Salek-Ardakani S., Harada Y., Luo J.L., Yang C., Croft M., Inoue K., Karin M., Liu Y.C. Convergence of Itch-induced ubiquitination with MEKK1-JNK signaling in Th2 tolerance and airway inflammation. J. Clin. Invest. 2006, 116:1117-1126.
21. Venuprasad K., Kong Y.C., Farrar M.A. Control of Th2-mediated inflammation by regulatory T cells. Am. J. Pathol. 2010, 177:525-531.
22. Wills-Karp M., et al. Interleukin-13: central mediator of allergic asthma. Science 1998, 18:2258-2261.
23. Zhang W.D., Chen H., Zhang C., Liu R.H., Li H.L., Chen H.Z. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med. 2006, 72:4-8.
24. Zhang Y., Zhu H., Huang C., Cui X., Gao Y., Huang Y., et al. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma. J. Cardiovasc. Pharmacol. 2006, 47:190-195.
25. + regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo. J. Immunol. 2006, 176:1609-1617.